See All AI raises $33M to advance its AI platform that generates 3D surgical images from 2D fluoroscopic X-rays, potentially reducing reliance on pre-op CT and MRI scans.
Key Details
- 1See All AI secured $33 million in funding for its imaging AI platform.
- 2The system converts 2D C-arm fluoroscopic X-rays into 'navigable' 3D volumes.
- 3Aims to reduce the need for pre-operative CT and MRI imaging.
- 4Platform is designed to support minimally invasive surgery workflows.
- 5Technology is not yet FDA-cleared or available clinically; U.S. approval sought this year.
- 6Cadaver studies show capability for high-resolution, cross-plane, 1 mm 3D slices.
Why It Matters
If successful, this technology could streamline surgical planning and reduce costs, radiation, and time in the operating room. It highlights growing industry investment and innovation aimed at augmenting or replacing traditional radiology workflows in perioperative imaging.
Source
Radiology Business
Related News
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.
•AuntMinnie
In-House LLM Accurately Flags Critical Pediatric Radiology Findings
A locally deployed LLM system at Stanford Health achieved 99.7% sensitivity for detecting critical results in pediatric radiology reports, supporting workflow automation.
•Cardiovascular Business
FDA Clears Elucid's AI-Driven FFR-CT Solution for Cardiac Imaging
Elucid's FFR-IQ, an AI-powered noninvasive FFR-CT tool, receives FDA clearance for clinical use.